Bob Langer-backed biotech plots $86M IPO as FDA filings loom By: Boston Business Journal via Business Journals June 26, 2017 at 10:10 AM EDT The eye drug developer, Kala Pharmaceuticals, is the third Massachusetts biotech to announce plans this month for an IPO. Read More >> Related Stocks: Mint Corp